What are the brand names of drugs used to treat Multiple Sclerosis (MS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025 • View editorial policy

From the Guidelines

Multiple Sclerosis Treatment Options

The primary disease-modifying therapies for Multiple Sclerosis (MS) include interferon beta-1a (Avonex, Rebif), interferon beta-1b (Betaseron, Extavia), glatiramer acetate (Copaxone), and fingolimod (Gilenya), as evidenced by various clinical trials 1, 2.

  • Other brand name medications used to treat MS include: + dimethyl fumarate (Tecfidera), which is administered orally at a dose of 240mg twice daily 2 + teriflunomide (Aubagio), with specific dosing regimens 2 + natalizumab (Tysabri), administered intravenously at a dose of 300mg every 4 weeks 2
  • Additionally, medications like alemtuzumab (Lemtrada) and ocrelizumab (Ocrevus) are used for relapsing-remitting MS, with dosing regimens typically consisting of 12mg/day for 5 days initially, followed by 12mg/day for 3 days at 12 months 2. These therapies have been shown to have varying effects on brain atrophy and disability outcomes in clinical trials, with some demonstrating a positive effect on reducing accrual of atrophy 1, 2.

From the FDA Drug Label

What is AVONEX AVONEX is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults.

Dimethyl fumarate delayed-release capsules are a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults

What is TYSABRI TYSABRI is a prescription medicine used to treat adults with: relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.

The brand names of drugs used to treat Multiple Sclerosis (MS) are:

  • AVONEX (interferon beta-1a)
  • TYSABRI (natalizumab)
  • Dimethyl fumarate (no brand name mentioned in the provided text, but it is known to be marketed under the brand name Tecfidera) 3, 4, 5

From the Research

Disease-Modifying Therapies for Multiple Sclerosis

The following are some of the brand names of drugs used to treat Multiple Sclerosis (MS):

  • Avonex (interferon beta-1a) 6, 7, 8, 9
  • Rebif (interferon beta-1a) 6, 7, 8, 9
  • Betaseron (interferon beta-1b) 6, 7, 8, 9
  • Extavia (interferon beta-1b) 10, 9
  • Copaxone (glatiramer acetate) 6, 7, 8, 9
  • Tysabri (natalizumab) 6, 7, 10, 8, 9
  • Gilenya (fingolimod) 6, 7, 10, 9
  • Aubagio (teriflunomide) 7, 10, 9
  • Tecfidera (dimethyl fumarate) 7, 10, 9
  • Lemtrada (alemtuzumab) 6, 7, 10, 9
  • Ocrevus (ocrelizumab) 6, 7, 9

Emerging Therapies

Some emerging therapies for MS include:

  • Laquinimod 7
  • Daclizumab 7, 9
  • Rituximab 9

Treatment Strategies

Treatment strategies for MS include sequential monotherapy, escalation therapy, and induction and maintenance therapy 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.